A major announcement was made recently in the world of pharmaceuticals. The company known around the world as EUSA Pharma has named a new person to take over their coveted position of President Europe. It will be a man named Carsten Thiel.
He has nearly 30 years of experience in the industry and has worked for a number of the world’s biggest and most respected pharma companies. EUSA Pharma is focused on oncology. However, they also dabble in rare diseases as well. The management of the company said that they are very happy with the appointment of Carsten Thiel to this very pivotal role in the company. They are confident that he will do a great job for them.
There had been rumors circulating for the past several months that EUSA Pharma was going to be shaking up their organization by giving promotions to several of their key employees. However, it was only a rumor at that point. Carsten Thiel has said in several interviews that he relished the challenge of being the man in charge of such a big division. He has worked his entire career to have this level of responsibility.
Carsten Thiel is originally from the city of Berlin in the country of Germany. He went to college at the University of Bristol. This school can be found in the United Kingdom. Thiel decided to focus on studying organic chemistry. He then went on to get a degree in biochemistry.
Finally, he attained a molecular biology PhD from the Max Planck Institute for Biophysical Chemistry. After he graduated from college, he went on to work for Hoffman la-Roche. It was at this company that Carsten Thiel made a name for himself in the pharma industry. Carsten has been a respected person ever since then and his reputation has grown.
Dr. Carsten Thiel is an expert in the field of biotechnology, who shares the view that the commercialization of gene therapies has become feasible as a result of ever-increasing efficiency and lower overhead involved in implementing technological innovations..